Research analysis · Governance

NATO's emerging-tech playbook and the governance of organoid intelligence

A peer-reviewed analysis of NATO's attempt to coordinate artificial intelligence, quantum computing, and other emerging technologies shows how alliances can govern fast-moving, dual-use fields. The same mechanisms matter for brain-organoid biocomputing, because the technology is crossing from bench science to commercial platforms before any shared rules exist.

Source: NATO and Emerging Technologies: The Alliance's Shifting Approach to Military Innovation, Stephen Herzog and Dominika Kunertova, Naval War College Review 77(2):47-70 (2024). Primary source. Read: the journal PDF via arXiv and the publisher's abstract page.

What the work claims

Herzog and Kunertova argue that NATO's traditional model of military innovation is mismatched to what the alliance calls emerging and disruptive technologies (EDTs), especially artificial intelligence and quantum computing.1 Unlike radar or nuclear weapons, the military utility of these technologies is less tangible early on, development is dominated by commercial firms rather than defense contractors, and member states have sharply different levels of investment and political interest. The article documents NATO's shift toward a more civil-military, commercially engaged coordination model and warns that success depends on new institutional habits: public-private partnerships, shared threat assessment, export controls, and soft regulatory norms.

The claim is institutional, not technical. The authors do not assert that NATO will master these technologies; they assert that mastering them requires changing how the alliance sets standards, shares burdens, and regulates dual-use flows.

How the coordination model works

The article identifies three pressure points that reshape NATO's approach. First, EDTs are capability-agnostic and privatized: the same large language model, quantum sensor, or semiconductor supply chain can serve civilian and military markets, so the old defense-industry procurement channel is too narrow.1 Second, member states are heterogeneous. The United States spends several times more on emerging technology annually than Europe collectively, in both public and private sectors, and many European allies have been hesitant to align with U.S. efforts to restrict Chinese access to militarily relevant dual-use technology.1 Third, the technologies have geostrategic prestige: Russian and Chinese leaders treat leadership in AI and quantum as a source of power, which makes standard-setting and export control part of alliance strategy.

NATO's response, as the authors describe it, is to move from a top-down, state-led innovation model to one that coordinates standards, adoption, and norms across governments, firms, and research institutions. The 2021 Brussels summit introduced language about protecting innovators and technology against misuse, and subsequent documents point toward soft law, export controls, and normative principles for EDT governance.1

Where a skeptic should push

The most load-bearing assumption is that NATO's military-coordination problem transfers to biomedical computing. The article never mentions organoids, brain tissue, or moral status, and the security stakes of organoid intelligence are not obviously the same as those of autonomous weapons or quantum decryption. A skeptic can argue that the analogy overstates the dual-use risk of neural organoid platforms and understates the unique welfare question: whether a cluster of living neurons can suffer, and who decides.

The evidence base is also qualitative. The authors rely on policy documents and interviews with NATO officials, not on quantitative measures of technology diffusion or standard adoption. That is appropriate for an institutional analysis, but it means the article shows how governance is being organized, not whether that organization is effective. Separately, the heterogeneous-investment problem in organoid intelligence is driven more by research funding and regulatory culture than by defense procurement, so the NATO prescription may need translation rather than direct application.

What NATO's coordination model means for organoid governance

The non-obvious implication is that organoid intelligence is entering the same governance gap NATO is trying to close. Brain organoids connected to microelectrode arrays, trained on closed-loop stimuli, and offered as computing substrates are a textbook emerging and disruptive technology: commercially driven, dual-use, technically immature, and distributed across jurisdictions with very different appetites for regulation.1 The field currently has no shared electrical or data standard, no agreed welfare threshold for a living neural culture, and no harmonized export-control treatment for high-density neural interfaces. NATO's experience suggests that waiting for a crisis to create those institutions is the wrong default.

The opportunity is institutional borrowing. Herzog and Kunertova describe a governance architecture that combines technical standardization, soft norms, and targeted controls. For organoid intelligence, that maps onto three practical needs. First, interface and reproducibility standards, so that a neural culture trained in one laboratory or vendor platform can be evaluated, shared, and compared on another. Second, a common framework for moral-status review, so that a culture with sustained, structured electrical activity is assessed against transparent criteria rather than ad hoc committee judgments. Third, export controls and supply-chain awareness for the specialized hardware, because high-density microelectrode arrays, low-noise amplifiers, and closed-loop training systems are already dual-use items even when sold for research.

The threat is capture by default. If the leading vendors and funding states set the rules informally, smaller actors inherit a standard they did not shape. The article notes that U.S. technological dominance can pull allies along even when their interests diverge.1 In organoid intelligence, that could mean that the first commercially successful platform becomes the de facto standard for neural readout, data format, and welfare thresholds, with limited input from ethicists, clinicians, or jurisdictions that are not leading the market. The worse outcome is fragmentation: every major region invents its own rules, making international collaboration, data sharing, and safety benchmarking harder.

The genuine governance lesson is anticipatory coordination. NATO's shift was triggered by great-power competition, but its structure, public-private engagement plus soft law plus targeted controls, is relevant before any security crisis arrives. For computing on living neural tissue, the moment to build that structure is now, while the platforms are still small and the moral-status questions are still contested.

The bottom line

What is established is that NATO is reorganizing how it coordinates emerging and disruptive technologies across allies with uneven investment and divergent interests, using a mix of standards, soft norms, and dual-use controls. What is extrapolation is that the same coordination architecture will be needed for organoid intelligence. The hypothesis would be strengthened by explicit moves in the organoid field: vendor-led standards bodies, national AI-and-biotech strategies that include neural tissue, or export-control classifications for high-density neural interfaces. It would be weakened if organoid computing remains a scattered research activity with no commercial scale, because then the coordination problem never materializes. The safest reading is that the NATO article provides a governance blueprint that the organoid field has not yet adopted.

Frequently asked questions

Does the NATO article discuss organoids?

No. It analyzes artificial intelligence, quantum computing, and other emerging military technologies. The application to organoid intelligence is an interpretive extension of its governance framework.

What is an emerging and disruptive technology in this context?

A technology whose military or strategic utility is still maturing, whose development is driven largely by commercial firms, and whose dual-use nature makes it hard to govern through traditional defense procurement.

Why is heterogeneous investment a governance problem?

When allies spend very different amounts on a technology and disagree on its strategic importance, they struggle to agree on standards, export controls, and shared research priorities.

What does soft law mean here?

Non-binding norms, guidelines, and best practices that shape behavior without being enforced like statutes or treaties. The article sees soft law as a flexible tool for fast-moving technologies.

How could this apply to brain-organoid computing?

The same features that make EDTs hard for NATO, commercial leadership, dual-use hardware, uneven regulation, and unclear standards, apply to organoid intelligence. The alliance's response offers a template for anticipatory governance.

What is the main risk of waiting?

Commercial platforms and dominant vendors may set de facto standards before public institutions agree on safety, welfare, and access rules, making later governance harder and more contentious.

References

  1. Herzog S, Kunertova D. NATO and Emerging Technologies: The Alliance's Shifting Approach to Military Innovation. Naval War College Review. 2024;77(2):47-70. https://digital-commons.usnwc.edu/nwc-review/vol77/iss2/5. Accessed 2026-08-26.